Evaluation of induction doses of propofol: Comparison between endstage renal disease and normal renal function patients

Anaesthesia and Intensive Care

Volumn 30, Issue 5, 2002, Pages 584-587

  Goyal, P ^a   Puri, G D ^a   Pandey, C K ^a   Srivastiva, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Monitoring: Bispectral index, depth of anaesthesia, intravenous; Propofol: Renal failure

Indexed keywords

ATRACURIUM; FENTANYL; HEMOGLOBIN; PROPOFOL;

ACIDITY; ADULT; ANEMIA; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPNOSIS; HYPOPROTEINEMIA; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PHARMACODYNAMICS; PREOPERATIVE EVALUATION; REGRESSION ANALYSIS; STUDENT T TEST; TITRIMETRY;

EID: 0036800345     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0203000506     Document Type: Article

References (20)

1. Ickx B, Cockshott ID, Barvaris L et al. Propofol infusion for induction and maintenance of anaesthesia in patients with end stage renal disease. Br J Anaesth 1998; 81:854-860.
2. De Gasperi A, Mazza E, Noe L et al. Pharmacokinetic profile of the induction doses of propofol in chronic renal failure patients undergoing renal transplantation. Minerva Anaesthesiol 1996; 62:25-31.
3. Morcos WE, Payne JP. The induction of anaesthesia with propofol ("Diprivan") compared in normal and renal failure patients. Postgrad Med J 1985; 61(suppl 3):62-63.
4. Elston AC, Bayliss MK, Park GR. Effect of renal failure on drug metabolism by the liver. Br J Anaesth 1993; 71:282-290.
5. Barter C, Sokol PP et al. Disposition and dose requirements of drugs in renal insufficiency. In: Seldin DW, Giebisch G. The Kidney-Physiology and Pathophysiology. 2nd Ed. Raven Press, New York 1992; 3671-3695.
6. Nathan N, Debord J, Narcisse F et al. Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and renal failure patients. A preliminary study. Acta Anaesthesiol Belgica 1993; 44:77-85.
7. Howard G, Wakeling M, John B et al. Targeting effect compartment or central compartment concentration of propofol. Anesthesiology 1999; 90:92-97.
8. Rampil IJ. A primer for signal processing in anesthesia. Anesthesiology 1998; 89:980-1002.
9. Todd MM. EEGs, EEG processing and the bispectral index. Anesthesiology 1998; 89:815-817.
10. Gillies GWA, Lees NW. The effect of speed of injection on induction with propofol. Anaesthesia 1989; 44:386-388.
11. Kirvella M, Olkkola KT, Rosenberg PH, Yli-Hankala A, Salmela K, Lindgren L. Pharmacokinetics of propofol and haemodynamic changes during induction of anaesthesia in uraemic patients. Br J Anaesth 1992; 68:178-182.
12. Christensen JH, Andersen F, Jansen J. Pharmacokinetics and pharmacodynamics of thiopental in patients undergoing renal transplantation. Acta Anaesthesiol Scand 1983; 27:513-518.
13. ICI-pharmaceuticals. Data on file.
14. Upton RN, Ludbrook GL, Grant C, Martinez AM. Cardiac output is the determinant of initial concentrations of propofol after short infusion administration. Anesth Analg 1999; 89:545-552.
15. Yushi UA, Yushi U, Watanabe K, Higuch H, Satoh T. The determinants of propofol induction of anesthesia dose. Anesth Analg 2001; 92:656-661.
16. Eckardt KU. Anaemia in end-stage renal disease: Pathophysiological considerations. Nephrol Dial Transplant 2001; 16 (Suppl 7):2-8.
17. Vanholder R, Landschoot NV, De Smet R et al. Drug protein binding in chronic renal failure: Evaluation of nine drugs. Kidney International 1988; 33:996-1004.
18. Garrido MJ, Jemenez RM, Rodriguez- Sasian JM, Aguire C, Aguilera L, Calvo R. Characterization of the binding of propofol to plasma protein and its possible interaction. Rev Esp Anest Reanimacion 1994; 41:308-312.
19. Kirkpatric T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol in elderly patients. Br J Anaesth 1988; 60:146-150.
20. Costela JL, Jimnez R, Calvo R, Suarez E, Carlos R. Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 1996; 40:741-745.